Clinic
Piney Woods Healthcare System, L.P.
Piney Woods Healthcare System, L.P. was paid $5.81M by Medicaid between May 2020 and Nov 2024, across 85 billing codes. Its largest line is 99283, emergency room visit (moderate) — 33% of everything it billed.
33Billing provider infoPINEY WOODS HEALTHCARE SYSTEM, L.P.
LUFKIN, TX 75904
LUFKIN, TX 75904
33aNPI1487607792assigned 05/18/2006
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$5.81M
24GClaims91,879
24DCodes billed85
24AFirst – last monthMay 2020 – Nov 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Texas
Rank by total paid#71 of 320
Median peer was paid$205K
This provider vs. median28×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 1,961 | $113K | |
| 2021 | 17,010 | $942K | |
| 2022 | 26,746 | $1.50M | |
| 2023 | 30,069 | $2.13M | |
| 2024incomplete | 16,093 | $1.13M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 33% | 13,454 | 12,751 | $1.90M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 29% | 7,457 | 6,994 | $1.67M |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 7.1% | 6,687 | 6,401 | $410K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5.5% | 3,383 | 3,256 | $319K |
| 71045 | Radiologic examination, chest; single view | 3.8% | 2,390 | 2,265 | $223K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 3.7% | 3,345 | 3,148 | $216K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.3% | 5,506 | 5,254 | $194K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.1% | 3,570 | 3,435 | $121K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1.8% | 718 | 672 | $104K |
| 80053 | Comprehensive metabolic panel | 1.7% | 7,223 | 6,473 | $98K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.3% | 7,882 | 7,123 | $75K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 439 | 430 | $56K |
73 more codes
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 1,169 | $54K |
| 86756 | <1% | 1,151 | $48K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,481 | $44K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 393 | $43K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 142 | $25K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 81 | $25K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 436 | $24K |
| 81001 | <1% | 5,130 | $21K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 786 | $14K |
| 81025 | <1% | 1,025 | $13K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 74 | $12K |
| 83735 | <1% | 1,537 | $9K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 132 | $8K |
| 83690 | <1% | 999 | $7K | |
| 84484 | <1% | 1,091 | $7K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 270 | $6K |
| 85027 | <1% | 805 | $5K | |
| 76818 | <1% | 28 | $5K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 183 | $5K |
| 87340 | <1% | 226 | $4K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 715 | $4K |
| 74018 | <1% | 29 | $4K | |
| 87634 | <1% | 25 | $3K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 875 | $3K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 15 | $3K |
| CP007 | <1% | 68 | $3K | |
| 81003 | <1% | 909 | $3K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 355 | $2K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,535 | $2K |
| G0378 | Hospital observation service, per hour | <1% | 14 | $2K |
| 83880 | <1% | 102 | $2K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 25 | $2K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 29 | $2K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 29 | $2K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 864 | $2K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 215 | $1K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 550 | $1K |
| 86850 | <1% | 103 | $1K | |
| 59025 | Fetal non-stress test | <1% | 15 | $1K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 356 | $1K |
| 86592 | <1% | 102 | $829.83 | |
| 84702 | <1% | 43 | $782.21 | |
| 85610 | <1% | 495 | $736.42 | |
| 86900 | <1% | 232 | $711.39 | |
| 83498 | <1% | 20 | $694.84 | |
| 86901 | <1% | 232 | $688.18 | |
| 85730 | <1% | 305 | $561.01 | |
| 83789 | <1% | 20 | $554.91 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 14 | $533.01 |
| 80306 | <1% | 15 | $463.41 | |
| 82261 | <1% | 20 | $431.42 | |
| 83605 | <1% | 71 | $380.92 | |
| 83520 | <1% | 20 | $372.11 | |
| 83020 | <1% | 20 | $329.27 | |
| 82776 | <1% | 20 | $270.14 | |
| 84437 | <1% | 20 | $165.53 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 242 | $112.70 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 52 | $103.06 |
| 86308 | <1% | 12 | $68.68 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 717 | $63.18 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 215 | $63.14 |
| 80061 | Lipid panel | <1% | 13 | $46.87 |
| 87186 | <1% | 13 | $29.42 | |
| 82550 | <1% | 13 | $18.84 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 14 | $17.63 |
| 85379 | <1% | 14 | $15.54 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 73 | $13.71 |
| 36415 | Collection of venous blood by venipuncture | <1% | 914 | $13.08 |
| 96375 | Therapeutic injection; each additional sequential IV push | 0% | 168 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 355 | $0.00 |
| 82962 | 0% | 325 | $0.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 41 | $0.00 |
| S3620 | Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) | 0% | 28 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Northwest Hospital LLC | Tucson, AZ | $47.81M |
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.